Literature DB >> 18037736

Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention.

Ali A Youssef1, Li-Teh Chang, Jiunn-Jye Sheu, Fan-Yen Lee, Sarah Chua, Kuo-Ho Yeh, Cheng-Hsu Yang, Chiung-Jen Wu, Hon-Kan Yip.   

Abstract

BACKGROUND: This study tested the hypothesis that in the acute phase of myocardial infarction (MI), the circulating level of soluble CD40 ligand (sCD40L), an index of platelet activation, is predictive of angiographic morphologic features that indicate high-burden thrombus formation (HBTF) in the infarct-related artery (IRA). METHODS AND
RESULTS: This prospective study included 162 consecutive patients: 64 with HBTF and 98 with low-burden thrombus formation (LBTF). All patients had a Killip's classification<or=3 ST-segment elevation acute myocardial infarction (AMI) of onset<12 h who were undergoing primary percutaneous coronary intervention (PCI). Blood samples for measurement of the circulating levels of sCD4L and high-sensitivity C-reactive protein (hs-CRP) and white blood cell (WBC) count were collected before PCI. The circulating levels of sCD40L and hs-CRP, and the WBC count were also evaluated in 20 normal control subjects. Blood was aspirated by export suction catheter from the intracoronary artery (ICA) in 49 HBTF patients. The WBC count, and the circulating levels of hs-CRP and sCD40L were significantly higher in the HBTF and LBTF groups than in the normal control subjects (all p<0.005). Additionally, the circulating levels of sCD40L and the WBC count were substantially higher in the HBTF than in the LBTF patients (all p<0.001). Furthermore, in HBTF patients the ICA had a significantly higher sCD40L level and WBC count compared with the values for the systemic circulation (all p<0.001). Multiple statistical analyses identified increased circulating level of sCD40L as the most independent predictor of HBTF in the IRA (p<0.0001).
CONCLUSIONS: The sCD40L level is the most independent predictor of angiographic morphologic features that indicate HBTF in the acute phase of MI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037736     DOI: 10.1253/circj.71.1857

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Prognostic evaluation of soluble CD40L in acute myocardial infarction: is not fancy, is science!

Authors:  Patrícia Napoleão; Miguel Mota Carmo; Teresa Pinheiro
Journal:  Ann Transl Med       Date:  2017-02

2.  The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Authors:  I Lambrinoudaki; M Karaflou; G Kaparos; O Grigoriou; A Alexandrou; C Panoulis; E Logothetis; M Creatsa; G Christodoulakos; E Kouskouni
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

3.  Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study.

Authors:  Mehmet Kayrak; Ahmet Bacaksiz; Mehmet S Ulgen; Mehmet Akif Vatankulu; Kadriye Zengin; Selim S Ayhan; Mustafa Kemal Basaralı; Sadik Büyükbas; Aysel Kiyici
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

4.  Correlates of Residual Thrombus Burden in Successfully Thrombolysed Patients of ST-Elevation Myocardial Infarction Receiving Dual Anti-Platelet Therapy.

Authors:  Parminder S Otaal; Abhinav Anand; Rajesh Vijayvergiya
Journal:  Cureus       Date:  2020-12-10

5.  Thrombus Aspirated from Patients with ST-Elevation Myocardial Infarction: Association between 3-Nitrotyrosine and Inflammatory Markers - Insights from ARTERIA Study.

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Luciano Consuegra-Sanchez; Pablo Avanzas; Alejandro Sanchez-Grande; Pablo Conesa-Zamora
Journal:  Int J Med Sci       Date:  2016-06-18       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.